Wikidata entity: Q66044391
Quantities
| P4135 | maximum age | 75 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 300 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q36 (Poland) | Poland |
| P17 | country | ... | Q214 (Slovakia) | Slovakia |
| P582 | end time | ... | 2018-08-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P131 | located in the administrative territorial entity | ... | Q1183 (Puerto Rico) | Puerto Rico |
| P1050 | medical condition | ... | Q12206 (diabetes) | diabetes |
| P4844 | research intervention | ... | Q21011228 (dulaglutide) | dulaglutide |
| P6153 | research site | ... | Q30269721 (Clinical Research of South Florida) | Clinical Research of South Florida |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270066 (Manhattan Medical Research) | Manhattan Medical Research |
| P580 | start time | ... | 2017-05-24 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase 2 Study of Once-Weekly LY3298176 Compared With Placebo and Dulaglutide in Patients With Type 2 Diabetes Mellitus | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03131687 |
Why not click here or view trends?
log id: 4852364